Xenoestrogens disrupt type 2 collagen expression in chondrocytes in vitro.  by Corvol, M.T. et al.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A136Methods: Cartilage slices were obtained from the advanced OA patients
(age 45-80 years) undergoing knee replacement surgery. Non-arthritic
knee cartilages were obtained from autopsy patients within 24h (NDRI,
Philadelphia). Three different rodent OA models, such as anterior cru-
ciate ligament transection (ACLT) and medial meniscectomy (MM) and
combination of both ACLT and MM models were performed. Prede-
signed TaqMan PCR primers were purchased from Applied Biosystems.
siRNA targeting periostin were purchased from Sigma. Matrix metal-
loproteinases proMMP-1 and proMMP-13 ELISA kits were from R&D
Systems. Degradation products of type II collagen was measured using
C1,2C - ELISA assay kit.
Results: Elevated expression of periostin (2-4 fold; p¼0.004) was
observed in OA compared to non-diseased control cartilage. Veriﬁcation
by real-time PCR, immunohistochemistry and immunoblot conﬁrmed
periostin upregulation in OA cartilage. In three different model of sur-
gical-induction of OA in rodents, such as anterior cruciate ligament
transection (ACLT) and destabilization of the medial meniscus (DMM)
and combination of both ACLT and MM models, periostin expression
signiﬁcantly increased (3-11 fold; p¼0.001) from 4-8 weeks after sur-
gery. In functional assays, exogenously added (1-10 mg/ml) or adeno-
virus mediated overexpression of periostin signiﬁcantly increased
MMP-13 (p<0.001) and ADAMTS4 (p<0.03) expression and activity
(p<0.02) in primary human OA and mouse chondrocytes. Conversely;
knock down of endogenous periostin using siRNA signiﬁcantly
decreased constitutive MMP-13 expression. In OA cartilage explants
cultures, periostin increased cartilage degradation, evidenced by
increased release of collagen (C1, 2C) and GAG fragments in culture
supernatants. Periostin selectively activates Wnt signaling and induc-
tion of MMP-13 and ADAMTS4 expression is mediated by b-catenin
signaling and inhibited by the Wnt inhibitor CCT031374 hydrobromide.
Conclusions: These ﬁndings characterize periostin as a catabolic
extracellular matrix protein in OA cartilage, where it acts via the can-
onical Wnt signaling pathway to promote cartilage degradation by
upregulating MMP-13 and aggrecanase expression. Therefore, periostin
may represent a novel therapeutic target to prevent OA progression.
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CARTILAGE SPECIFIC DELETION OF MITOGEN INDUCIBLE GENE 6 IN
MICE INCREASES ARTICULAR CARTILAGE THICKNESS IN LATE
ADULTHOOD
M.A. Pest y, B. Russell y, J.-W. Jeong z, F. Beier y. yUniv. of Western Ontario,
London, ON, Canada; zMichigan State Univ., Grand Rapids, MI, USA
Purpose: Osteoarthritis (OA) is a degenerative joint disease which is
characterized by the progressive loss of articular cartilage thickness and
overall joint degeneration. There are currently no treatments to slow,
stop or reverse joint destruction, and so therapeutics for OA only mit-
igate symptoms of pain/stiffness. Mitogen inducible gene 6 (Mig-6)
negatively regulates epidermal growth factor (EGFR) signalling which is
important in cartilage homeostasis (Appleton et al, 2010). We have
shown previously that loss of Mig-6 in mouse cartilage results in
increased articular cartilage thickness and ectopic formation of chon-
dro-osseous nodules in the knee (Pest et al, 2014). However, it is unclear
whether these anabolic effects are observed in other joints, and if
altered cartilage homeostasis can be induced post-natally.
Purpose: To determine 1) the role of Mig-6 in maintaining cartilage
anabolism when deleted in post-natal mouse cartilage, 2) the anabolic
effects of Mig-6 loss in multiple joints and at multiple ages, and 3)
whether this phenotype can be rescued by deletion of EGFR ligand
TGFalpha.
Methods: Selective knockout of Mig-6 in cartilage was achieved
through the use of the Cre-lox system, by breeding “ﬂoxed”Mig-6 (Mig-
6ﬂ/ﬂ) mice to either animals with Cre driven by Col2a1 promoter (Col2-
Creþ/-) or to animals with an inducible Col2a1 driven Cre (Col2a1-
CreERT2þ/-). Col2-Cre mice were aged to 15 and 21 months of age to
examine cartilage anabolism and formation of ectopic chondro-osseous
nodules late in life. 21 month old mice were scanned by MicroCT at 50
mm/voxel resolutions to examine changes in bone morphology and
ectopic nodule formation. Cre-mediated recombination in Col2-CreER
mice was induced by 5 day tamoxifen injection in 3week old mice. Mice
with deletion of TGFalpha were bred to Mig-6 KO mice to evaluate the
role of this EGFR ligand in the anabolic phenotype. Histological sections
of knee, ankle, elbow and spine articular joints were collected and joint
morphology was examined using various stains including Safranin O/fast green, toluidine blue and picrosirius red. Immunohistochemistry
(IHC) was used to evaluate molecular changes in joint tissues.
Results: Anabolic increase in the cartilage thickness of the elbow and
ankle was observed up to the age of 21 months in Mig-6 knockout mice
(KO, Mig-6ﬂ/ﬂ;Col2-Creþ/-) when compared to Control mice (Mig-6ﬂ/
ﬂ;Col2-Cre-/- or Mig-6ﬂ/þ;Col2-Cre-/-). Ectopic chondro-osseous nod-
ules were identiﬁed only in the knee joints and spines of KO mice by
MicroCT evaluation and histology. Phospho-ERK staining in these tis-
sues was increased in KO mice compared to control, indicating
increased EGFR signalling. Deletion of TGFalpha in Mig6 KO did not
prevent formation of chondro-osseous nodules in the knee as late as 12
weeks of age.
Conclusions: The anabolic effects of Mig6 loss in mouse cartilage can
persist late into adulthood, however the exact mechanism is still
unclear. Mig6 and the EGFR signalling pathway may be promising tar-
gets for the development of therapeutic interventions which induce
cartilage anabolism and repair in OA diseased tissue.
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XENOESTROGENS DISRUPT TYPE 2 COLLAGEN EXPRESSION IN
CHONDROCYTES IN VITRO.
M.T. Corvol, Sr., T. Auxietre, M.-F. Dumontier, O. Kellerman,
J.-F. Savouret. INSERM, Paris, France
Purpose: In recent years chemicals with endocrine properties, called
Endocrine Disrupting Compounds (EDC), have become a topic of sci-
entiﬁc and public discussion. In the ﬁeld of osteoarthritic pathologies,
EDC compounds that mimic estrogenic agonists or antagonists are of
major concern, because of the central role of estrogens in skeletal
developmental processes (ref). EDC are acting on their target genes
upon binding the aryl hydrocarbon receptor (AhR). During the ten past
years, interactions between estrogen receptor (ER) and some xeno-
biotic-activated AhR have been well demonstrated. Very few studies
have been reported on EDC effects on bone or cartilage. Our laboratory
recently studied the effects of low doses and cocktail xenoestrogens on
rat cartilage development in vivo, by using a rodent gestational/lacta-
tional model (T.A. Auxietre, et al, 2014). We observed transient mod-
iﬁcations of caudal vertebral body associated with a decrease in growth
plate cartilage thickness with greater impact on the hypertrophic
chondrocyte zone. We inferred from these data that the tested com-
pounds could interfere with the dynamic of chondrogenic differ-
entiation and/or maturation processes, possibly by impacting type 2
collagen (Col2), one of the the major components of cartilage that
assures cartilage function.
The present work was aimed to study the in vitro effects of two xen-
oestrogens (genistein, G; bisphenol A, BPA) and one anti-androgen
(vinclozolin, V) and its metabolite M2 on Col2 expression in two dif-
ferent models of cultured chondrocytes: during the process of chon-
drogenic induction and in mature chondrocytes.
Methods: A murine stem cell line inducible towards chondrogenesis
(C1) was used for dynamic studies of differentiation using chondrogenic
and non-chondrogenic markers. In parallel, post-natal murine chon-
drocytes were used for steady-state investigations in differentiated
chondrocytes in primary culture (P0) or after dedifferentiation by pas-
sages (P3) or FGF2 treatment. Biological markers were studied at the
mRNA (qPCR) and protein (western blot) levels. COL2A protein
expression was evaluated by western blot and immunocytochemistry
by using an antibody which only recognizes the speciﬁc COL2A N-ter-
minal propeptide. Fulvestrant and SB 203580 were used respectively as
speciﬁc inhibitors of ER or p38MEK pathways. Implication of Tia1-
splicing was shown after cell transfectionwith speciﬁc anti-Tia1 siRNAs.
Results: Vinclozolin was practically inactive. M2, alone or combined
with G or BPA, modiﬁed the dynamic of Col2A immature isoform of
COL2 during chondrogenic induction. These compounds extended the
basal expression of COL2A and delayed its replacement by the mature
isoform COL2B in C1 cells. This effect was dose dependent with max-
imum at 10-6M. In post natal chondrocytes, COL2A expression
increased with cell dedifferentiation or FGF2 treatment. EDC were
inactive on differentiated chondrocytes while COL2A doubled upon M2,
G and BPA addition in dedifferentiated cells. Estrogen receptor (ER) and
the p38-MEK pathway were involved. As these effects were only partly
transcriptional, we investigated and found an effect of FGF2 on Tia-1
splice protein expression. EDC showed no effects on other chondrogenic
markers (SOX9, Aggrecan, Col10a1) nor non-chondrogenic markers.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A137Conclusions: These data showed that xenosestrogens as well as the
vinclozolin metabolite M2 modiﬁed the rate of early chondrogenic
differentiation by transiently maintaining COL2A expression. Our
hypothesis is that COL2A induced persistence, might provoke matrix
weakening in the long term and/or sequester growth factors, eventually
modifying the course of cartilage degenerative diseases such as osteo-
arthritis. EDC also modiﬁed COL2A expression in dedifferentiated
chondrocytes such as found in aging or osteoarthritic tissues. These data
are in accordance with the strong Col2A expression reported in OA
cartilage but its role remains to be studied.
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QUANTITATIVE PROTEOMICS OF ARTICULAR CARTILAGE USING
SEQUENTIAL EXTRACTION OF TRANSVERSE CRYOSECTIONS
M.-F. Hsueh y, V.B. Kraus z, A. Khabut x, P. €Onnerfjord x. yDept. of
Pathlogy, Duke Univ., Durham, NC, USA; zDept. of Med., Duke Univ.,
Durham, NC, USA; xDept. of Clinical Sci., Lund Univ., Lund, Sweden
Purpose: Articular cartilage is a highly cross-linked tissue. Because the
insoluble collagen-rich residues are left behind after commonly used
guanidine-HCl (Gu-HCl) extraction, the composition of the insoluble
residue has not been fully elucidated. Moreover, articular cartilage has a
variety of microenvironments varying by distance from the surface
(superﬁcial, middle, and deep layers) or distance from the chondrocyte
(pericellular, territorial and interterritorial zones). We hypothesize that
during joint damage, the catabolic activities and the rate of protein
synthesis vary between these subregions. The goal of this study was to
quantify the amount of extractable and non-extractable protein and to
elucidate the differences between subregions in different joints (hip
and knee) and under different physiological conditions (healthy and
osteoarthritis).
Methods: We collected hip and knee cartilage samples (healthy and
osteoarthritic) as surgical waste from surgical repair of trauma or joint
replacement. Transverse cryosections were generated by distance from
the surface. To avoid the confounding background by intracellular
proteins, chondrocytes were depleted by performing one rapid freeze/
thaw cycle in hypotonic solution. We performed Gu-HCl extraction to
obtain extractable proteins from knee cartilage sections and in situ
trypsin digestion to extract proteins from the insoluble residue. An
adjacent set of cartilage sections from knee and hip cartilage were
acquired for toluidine blue staining to distinguish different zones. By
laser capture microscopy (LCM, Carl Zeiss PALM Microbeam), we pre-
cisely sampled (~2 mm2 area samples) the cartilage matrix from the
territorial (T) and interterritorial (IT) matrix zones from each layer. We
performed in situ trypsin digestion of these LCM-harvested samples to
extract all proteins including portions of the insoluble residue
remaining after Gu-HCl extraction. All batches of extracts were quan-
tiﬁed using multiple reaction monitoring (MRM) by a triple quadropole
instrument (TSQ-Vantage, Thermo). We calculated the ratio of
extractable to total protein (sum of extractable and non-extractable)
and deﬁned this value as extractability.
Results: As expected, aggrecan core protein was readily extracted by
Gu-HCl methods. It was noteworthy that the extractability of cartilage
intermediate layer protein (CILP) 1-1 increased with cartilage depth in
arthritic cartilage, but decreased in healthy cartilage. However, the
extractability of CILP 1-2 increased with cartilage depth in both types of
cartilage. In arthritic cartilage, a signiﬁcant increase of extractability
was identiﬁed in several proteins, including ﬁbronectin (FINC) and
cartilage acidic protein 1 (CRAC1). We also investigated the protein
distribution in distinct and precisely sampled subregions of cartilage.
Similar to previous work focused on aggrecan core protein, the amount
of all three aggrecan subdomains increased in the deeper regions. The
aggrecan G3 domain accumulated in the territorial regions while the G1
and G2 domains accumulated in the interterritorial regions. These
patterns were the same in both healthy knee and hip cartilage.
Conclusions: Characterization of the precise cartilage matrix archi-
tecture by subregions can provide insights into protein networks and
signaling as well a reﬁned understanding of the catabolic and anabolic
responses to arthritis. Interestingly, the extractability by Gu-HCl of
some matrix proteins was increased in arthritic cartilage suggesting
either increased amounts of protein and/or altered protein interactions
to make them more readily dissociated from the cartilage meshwork.
Our LCM experimental system coupled with modern proteomic tool
was validated by the comparability of our results for aggrecan domains
by subregion with what is known in the literature. Ongoing analysis ofother targeted proteins will be expected to provide a compelling new
and comprehensive understanding of their distributionwithin cartilage
and a global understanding of matrix architecture in health and disease.
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IMPAIRED LONG BONE GROWTH IN CHONDROCYTE-SPECIFIC ERP57
KNOCKOUT MICE IS INDUCED BY ER STRESS
A. Linz y, Y. Knieper y, T. Gronau z, A. Aszodi x, N. Garbi 4,
G.J. H€ammerling ¶, T. Pap#, P. Bruckner y, R. Dreier y. yWestfalian
Wilhelms Univ., Inst. of Physiological Chemistry and Pathobiochemistry,
Münster, Germany; zUniv. Hosp. Münster, Inst. of Experimental
Musculoskeletal Med. (IEMM), Münster, Germany; x Experimental
Surgery and Regenerative Med., Dept. of Surgery, Ludwig-Maximilians-
Univ., München, Germany; kUniv. of Bonn, Dept. of Molecular
Immunology, Inst. of Molecular Med. and Experimental Immunology,
Bonn, Germany; ¶Div. Molecular Immunology, German Cancer Res. Ctr.,
Heidelberg, Germany; #Universtity Hosp. Münster, Inst. of Experimental
Musculoskeletal Med. (IEMM), Münster, Germany
Purpose: During long bone growth by endochondral ossiﬁcation
chondrocytes produce large amounts of extracellular matrix macro-
molecules. Before folding and entering the secretory pathway, these
molecules are subject to extensive post-translational modiﬁcation,
orchestrated by chaperone complexes in the endoplasmic reticulum
(ER). ERp57 is a member of the protein disulﬁde isomerase (PDI) family
and facilitates correct folding of newly synthesized glycoproteins by
rearrangement of native disulﬁde bonds. Here, we analyzed the func-
tional role of ERp57 in bone development and growth in vivo.
Methods: Cartilage speciﬁc ERp57 knockout (KO) mice were generated
by mating ERp57 ﬂx/ﬂx mice with mice expressing alpha1 Collagen II-
driven cre-recombinase. Size, weight, and bone length was determined
in KO and wild type (WT) littermates at post-natal days 1, 7, 12 and at 1
and 2 months. Parafﬁn-embedded legs were analyzed by extensive
histological, immunohistological and TUNEL staining. Tibiae of 1 month
old mice were investigated by micro-computed tomography.
Results: The mice were viable, had a normal lifespan, and were fertile.
However, their post-natal weight gain and growth of long bones was
retarded, suggesting that ERp57 function is required for normal skeletal
development and growth. The differences between KO and WT animals
in male mice were maximal at the time of their pubertal growth spurt.
Loss of ERp57 triggered ER stress, unfolded protein response, reduced
proliferation and accelerated apoptotic cell death of chondrocytes.
Together this resulted in a delay of long bone growth with the following
characteristics: 1. enlarged growth plates; 2. expanded hypertrophic
zones; 3. retarded osteoclast recruitment; 4. delayed remodeling of the
proteoglycan-rich matrix and 5. delayed formation of trabecular bone in
the primary and secondary ossiﬁcation centers. All the growth plate
abnormalities, however, became attenuated after the pubertal growth
spurt, when protein synthesis is decelerated and, hence, ERp57 chap-
erone function is less essential.
Conclusions: ERp57-dependent protein disulﬁde isomerase activity is
crucial for skeletal development and growth. Loss of ERp57 chaperone
function results in ER stress and delays bone growth especially during
the pubertal growth spurt when matrix deposition is particularly
intensive.
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TGF-BETA BLOCKS CHONDROCYTE HYPERTROPHY AND MAINTAINS
CELL VIABILITY IN CULTURED CARTILAGE EXPLANTS BUT DOES
NOT PROTECT AGAINST PROTEOGLYCAN LOSS
A.P. van Caam, W. Madej, H.M. van Beuningen, E.N. Blaney Davidson,
P.M. van der Kraan. Radboud Univ. Med. Center, Nijmegen, Netherlands
Purpose: Degradation of the extracellular matrix of cartilage is a key
aspect of osteoarthritis. In part, this degradation is due to chondrocytes
gaining a hypertrophy-like phenotype, characterized by increased
production of matrix metalloproteinase 13 (Mmp13) and collagen type
X (Col10a1). TGFb1 is considered to be a protective factor for articular
cartilage. It is able to block hypertrophy and able tomaintain or increase
production of glycosaminoglycans (GAG), an essential matrix compo-
nent. These functions of TGFb1 havemainly been identiﬁed using either
stem cells or very young cartilage. However, TGFb1-signaling is differ-
ent in mature cartilage compared to young cartilage. Therefore, we
investigated the effect of TGFb1-signaling on healthy mature cartilage
